Paul Tudor Jones II's position in Veracyte is currently worth $635 Thousand. That's 0.01% of their equity portfolio (1042nd largest holding). The first Veracyte trade was made in Q4 2020. Since then Paul Tudor Jones II bought shares seven more times and sold shares on seven occasions. The stake costed the investor $435 Thousand, netting the investor a gain of 46% so far.